Condition: Malaria · Sponsor: Kintampo Health Research Centre, Ghana
The ongoing Malaria Vaccine Pilot Evaluation (MVPE) is being conducted in Ghana, Malawi and Kenya through community and sentinel hospital surveillance systems and a series of household surveys (to measure vaccine coverage). The Malaria Vaccine Pilot Evaluation-Case Control (MVPE-CC) registered here as observational study is embedded within MVPE comprising case-control studies of clinical and mortality outcomes. Each case will require four controls, and caregiver informed consent will be required prior to study activities. These observational case control studies will measure as complementary information to what is being collected through MVPE: 1. Safety among children who received the malaria vaccine, with focus on cerebral malaria, meningitis and severe malaria 2. The impact of the malaria vaccine on all-cause mortality for boys and girls, AND 3. Promote use of case-control approaches by Expanded Programmes on Immunization (EPI) and malaria control programmes.
This description comes directly from the study's public registry record.
Thomas Gyan · 0208398541 · thomas.gyan@kintampo-hrc.org
Always discuss trial participation with your own doctor first.
| Kintampo Health Research Centre | Kintampo, Ghana | Recruiting |
| African Research Collaboration for Health Limited | Nairobi, Kenya | Recruiting |
| Kenya Medical Research Institute (KEMRI) | Nairobi, Kenya | Recruiting |
| College of Medicine, University of Malawi | Blantyre, Malawi | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05041556